218 related articles for article (PubMed ID: 20691590)
1. Disorders of muscle lipid metabolism: diagnostic and therapeutic challenges.
Laforêt P; Vianey-Saban C
Neuromuscul Disord; 2010 Nov; 20(11):693-700. PubMed ID: 20691590
[TBL] [Abstract][Full Text] [Related]
2. Myopathies caused by disorders of lipid metabolism.
Carroll JE
Neurol Clin; 1988 Aug; 6(3):563-74. PubMed ID: 3065601
[TBL] [Abstract][Full Text] [Related]
3. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
Stanley CA
Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
[TBL] [Abstract][Full Text] [Related]
4. Lipid storage myopathies.
Bruno C; Dimauro S
Curr Opin Neurol; 2008 Oct; 21(5):601-6. PubMed ID: 18769256
[TBL] [Abstract][Full Text] [Related]
5. Carnitine deficiency disorders in children.
Stanley CA
Ann N Y Acad Sci; 2004 Nov; 1033():42-51. PubMed ID: 15591002
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic assessment and long-term follow-up of 13 patients with Very Long-Chain Acyl-Coenzyme A dehydrogenase (VLCAD) deficiency.
Laforêt P; Acquaviva-Bourdain C; Rigal O; Brivet M; Penisson-Besnier I; Chabrol B; Chaigne D; Boespflug-Tanguy O; Laroche C; Bedat-Millet AL; Behin A; Delevaux I; Lombès A; Andresen BS; Eymard B; Vianey-Saban C
Neuromuscul Disord; 2009 May; 19(5):324-9. PubMed ID: 19327992
[TBL] [Abstract][Full Text] [Related]
7. Disorders of lipid metabolism in muscle.
Di Mauro S; Trevisan C; Hays A
Muscle Nerve; 1980; 3(5):369-88. PubMed ID: 7421873
[TBL] [Abstract][Full Text] [Related]
8. Heat stress deteriorates mitochondrial beta-oxidation of long-chain fatty acids in cultured fibroblasts with fatty acid beta-oxidation disorders.
Li H; Fukuda S; Hasegawa Y; Purevsuren J; Kobayashi H; Mushimoto Y; Yamaguchi S
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1669-72. PubMed ID: 20207594
[TBL] [Abstract][Full Text] [Related]
9. Acquired multiple Acyl-CoA dehydrogenase deficiency in 10 horses with atypical myopathy.
Westermann CM; Dorland L; Votion DM; de Sain-van der Velden MG; Wijnberg ID; Wanders RJ; Spliet WG; Testerink N; Berger R; Ruiter JP; van der Kolk JH
Neuromuscul Disord; 2008 May; 18(5):355-64. PubMed ID: 18406615
[TBL] [Abstract][Full Text] [Related]
10. In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique.
Jakobs C; Kneer J; Martin D; Boulloche J; Brivet M; Poll-The BT; Saudubray JM
Eur J Pediatr; 1997 Aug; 156 Suppl 1():S78-82. PubMed ID: 9266222
[TBL] [Abstract][Full Text] [Related]
11. Primary carnitine deficiency in a male adult.
Karmaniolas K; Ioannidis P; Liatis S; Dalamanga M; Papalambros T; Migdalis I
J Med; 2002; 33(1-4):105-10. PubMed ID: 12939109
[TBL] [Abstract][Full Text] [Related]
12. Primary and secondary carnitine deficiency syndromes.
Pons R; De Vivo DC
J Child Neurol; 1995 Nov; 10 Suppl 2():S8-24. PubMed ID: 8576570
[TBL] [Abstract][Full Text] [Related]
13. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
[TBL] [Abstract][Full Text] [Related]
14. Carnitine supplementation induces acylcarnitine production in tissues of very long-chain acyl-CoA dehydrogenase-deficient mice, without replenishing low free carnitine.
Primassin S; Ter Veld F; Mayatepek E; Spiekerkoetter U
Pediatr Res; 2008 Jun; 63(6):632-7. PubMed ID: 18317232
[TBL] [Abstract][Full Text] [Related]
15. Concerted action of leptin in regulation of fatty acid oxidation in skeletal muscle and liver.
Wein S; Ukropec J; Gasperíková D; Klimes I; Seböková E
Exp Clin Endocrinol Diabetes; 2007 Apr; 115(4):244-51. PubMed ID: 17479441
[TBL] [Abstract][Full Text] [Related]
16. Neonatal screening for very long-chain acyl-coA dehydrogenase deficiency: enzymatic and molecular evaluation of neonates with elevated C14:1-carnitine levels.
Liebig M; Schymik I; Mueller M; Wendel U; Mayatepek E; Ruiter J; Strauss AW; Wanders RJ; Spiekerkoetter U
Pediatrics; 2006 Sep; 118(3):1065-9. PubMed ID: 16950999
[TBL] [Abstract][Full Text] [Related]
17. Infantile Pompe's disease, lipid storage, and partial carnitine deficiency.
Verity MA
Muscle Nerve; 1991 May; 14(5):435-40. PubMed ID: 1870635
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency.
Bonnefont JP; Bastin J; Laforêt P; Aubey F; Mogenet A; Romano S; Ricquier D; Gobin-Limballe S; Vassault A; Behin A; Eymard B; Bresson JL; Djouadi F
Clin Pharmacol Ther; 2010 Jul; 88(1):101-8. PubMed ID: 20505667
[TBL] [Abstract][Full Text] [Related]
19. Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders.
Djouadi F; Aubey F; Schlemmer D; Ruiter JP; Wanders RJ; Strauss AW; Bastin J
Hum Mol Genet; 2005 Sep; 14(18):2695-703. PubMed ID: 16115821
[TBL] [Abstract][Full Text] [Related]
20. Primary carnitine deficiency: adult onset lipid storage myopathy with a mild clinical course.
Vielhaber S; Feistner H; Weis J; Kreuder J; Sailer M; Schröder JM; Kunz WS
J Clin Neurosci; 2004 Nov; 11(8):919-24. PubMed ID: 15519880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
